• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥沙拉嗪对大鼠空肠的作用。

Effects of olsalazine in the jejunum of the rat.

作者信息

Mohsen A Q, Mulvey D, Priddle J D, Parsons D S, Jewell D P

出版信息

Gut. 1987 Mar;28(3):346-52. doi: 10.1136/gut.28.3.346.

DOI:10.1136/gut.28.3.346
PMID:3570038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1432687/
Abstract

Olsalazine (ADS) is the azo-linked dimer of 5-aminosalicylic acid (5-ASA). It is of value for the management of patients with ulcerative colitis but may be associated with increasing diarrhoea in a few. This study examines the effect of 5-ASA and ADS on small intestinal transport systems of the rat. Krebs-Ringer-bicarbonate solution was circulated through the lumen of a jejunal segment and the appearance of fluid, glucose and lactate on the serosal surface was shown to be linear over a two hour period. Addition of 5-ASA (10 mmol/l) or ADS (5 mmol/l and 10 mmol/l) caused a significant inhibition both of fluid transport (p less than 0.001), and of the appearance of glucose (p less than 0.001) and lactate (p less than 0.001 for 5 mmol/l and 10 mmol/l ADS, p less than 0.01 for 10 mmol/l 5-ASA). The uptake of glucose by rings of rat jejunum was shown to be markedly reduced by ADS. Experiments substituting glucose with either sucrose of 2-aminoisobutyric acid showed that ADS (5 mmol/l, 10 mmol/l) also inhibited the serosal appearance of fructose and the amino acid. These results show that 5-ASA and ADS, at concentrations which could be expected in the jejunum of patients receiving therapeutic doses, are able to inhibit small intestinal transport systems. The resulting increase in load on the diseased colon could be important for the pathogenesis of diarrhoea.

摘要

奥沙拉嗪(ADS)是5-氨基水杨酸(5-ASA)的偶氮连接二聚体。它对溃疡性结肠炎患者的治疗有价值,但少数患者可能会出现腹泻加重的情况。本研究考察了5-ASA和ADS对大鼠小肠转运系统的影响。 Krebs-Ringer碳酸氢盐溶液在空肠段腔内循环,结果显示在两小时内,浆膜表面液体、葡萄糖和乳酸的出现呈线性关系。添加5-ASA(10 mmol/L)或ADS(5 mmol/L和10 mmol/L)会显著抑制液体转运(p<0.001),以及葡萄糖(p<0.001)和乳酸的出现(5 mmol/L和10 mmol/L的ADS,p<0.001;10 mmol/L的5-ASA,p<0.01)。结果表明,ADS可显著降低大鼠空肠环对葡萄糖的摄取。用蔗糖或2-氨基异丁酸替代葡萄糖的实验表明,ADS(5 mmol/L,10 mmol/L)也会抑制果糖和氨基酸在浆膜表面的出现。这些结果表明,在接受治疗剂量的患者空肠中预期会出现的浓度下,5-ASA和ADS能够抑制小肠转运系统。患病结肠负荷的增加可能对腹泻的发病机制很重要。

相似文献

1
Effects of olsalazine in the jejunum of the rat.奥沙拉嗪对大鼠空肠的作用。
Gut. 1987 Mar;28(3):346-52. doi: 10.1136/gut.28.3.346.
2
Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects.奥沙拉嗪和柳氮磺胺吡啶对正常人体空肠和回肠水及电解质吸收的影响。
Gut. 1991 Mar;32(3):270-4. doi: 10.1136/gut.32.3.270.
3
Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.溃疡性结肠炎缓解期患者从奥沙拉嗪和Eudragit L包衣美沙拉嗪中全身吸收5-氨基水杨酸的情况。
Z Gastroenterol. 1996 Apr;34(4):225-9.
4
Absorption and metabolism of fructose by rat jejunum.大鼠空肠对果糖的吸收与代谢
Biochem J. 1984 Aug 15;222(1):57-64. doi: 10.1042/bj2220057.
5
Olsalazine-related diarrhoea: does rat intestine adapt in vivo?奥沙拉嗪相关性腹泻:大鼠肠道在体内会产生适应性变化吗?
Scand J Gastroenterol. 1992 Apr;27(4):311-6. doi: 10.3109/00365529209000080.
6
Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.溃疡性结肠炎患者中奥沙拉嗪和三种美沙拉嗪制剂对5-氨基水杨酸的处置:结肠腔内浓度、血清值及尿排泄的比较
Gut. 1990 Nov;31(11):1271-6. doi: 10.1136/gut.31.11.1271.
7
Sulphasalazine, olsalazine and sulphapyridine induce mitogenic actions in the rat intestinal epithelium.柳氮磺胺吡啶、奥沙拉嗪和磺胺吡啶可诱导大鼠肠上皮细胞的促有丝分裂作用。
APMIS. 1997 Sep;105(9):717-22. doi: 10.1111/j.1699-0463.1997.tb05076.x.
8
Effect of olsalazine and mesalazine on intraluminal pH of the duodenum and proximal jejunum in healthy humans.奥沙拉嗪和美沙拉嗪对健康人十二指肠和空肠近端腔内pH值的影响。
Scand J Gastroenterol. 1994 Jun;29(6):498-500. doi: 10.3109/00365529409092461.
9
Absorption of 5-fluorouracil and related pyrimidines in rat small intestine.5-氟尿嘧啶及相关嘧啶在大鼠小肠中的吸收
Clin Sci (Lond). 1987 Jun;72(6):705-16. doi: 10.1042/cs0720705.
10
The stimulation of glucose absorption and metabolism in rat jejunum by bradykinin: dependence on the composition of commercial diets.缓激肽对大鼠空肠葡萄糖吸收和代谢的刺激作用:取决于市售日粮的成分。
Biochim Biophys Acta. 1989 Jul 21;992(1):128-30. doi: 10.1016/0304-4165(89)90059-7.

引用本文的文献

1
Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase. A possible diarrhogenic factor?奥沙拉嗪和美沙拉嗪对人回肠及结肠(钠+钾)-ATP酶的作用。一个可能的致腹泻因素?
Clin Investig. 1993 Apr;71(4):286-9. doi: 10.1007/BF00184728.
2
Optimum dose of olsalazine for maintaining remission in ulcerative colitis.奥沙拉嗪维持溃疡性结肠炎缓解的最佳剂量
Gut. 1994 Sep;35(9):1282-6. doi: 10.1136/gut.35.9.1282.
3
Effect of olsalazine on sodium-dependent bile acid transport in rat ileum.奥沙拉嗪对大鼠回肠钠依赖性胆汁酸转运的影响。
Dig Dis Sci. 1995 May;40(5):943-8. doi: 10.1007/BF02064181.
4
Medical treatment of ulcerative colitis: scoring the advances.溃疡性结肠炎的医学治疗:评估进展
Gut. 1988 Oct;29(10):1298-303. doi: 10.1136/gut.29.10.1298.
5
Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.比较奥沙拉嗪和柳氮磺胺吡啶用于溃疡性结肠炎维持治疗的对照试验。
Gut. 1988 Jun;29(6):835-7. doi: 10.1136/gut.29.6.835.
6
Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease.新型基于5-氨基水杨酸的药物在慢性炎症性肠病中的应用
Drugs. 1989 Jan;37(1):73-86. doi: 10.2165/00003495-198937010-00005.
7
Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease.
Drugs. 1991 Apr;41(4):647-64. doi: 10.2165/00003495-199141040-00009.
8
Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects.奥沙拉嗪和柳氮磺胺吡啶对正常人体空肠和回肠水及电解质吸收的影响。
Gut. 1991 Mar;32(3):270-4. doi: 10.1136/gut.32.3.270.
9
Drug therapy of ulcerative colitis.溃疡性结肠炎的药物治疗
Br J Clin Pharmacol. 1992 Sep;34(3):189-98. doi: 10.1111/j.1365-2125.1992.tb04124.x.
10
Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.奥沙拉嗪与柳氮磺胺吡啶在溃疡性结肠炎维持治疗12个月期间的预防效果。丹麦奥沙拉嗪研究小组。
Gut. 1992 Feb;33(2):252-5. doi: 10.1136/gut.33.2.252.

本文引用的文献

1
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.偶氮双水杨酸二钠在健康志愿者体内的分布与代谢,偶氮双水杨酸二钠是一种潜在的溃疡性结肠炎治疗药物。
Gut. 1982 Dec;23(12):1081-7. doi: 10.1136/gut.23.12.1081.
2
Application of high performance liquid chromatography to study transport and metabolism of nucleic acid derivatives by rat jejunum in vitro: endogenous washout.高效液相色谱法在研究大鼠空肠体外转运和代谢核酸衍生物中的应用:内源性洗脱
Q J Exp Physiol. 1983 Jan;68(1):39-51. doi: 10.1113/expphysiol.1983.sp002701.
3
Absorption and metabolism of fructose by rat jejunum.大鼠空肠对果糖的吸收与代谢
Biochem J. 1984 Aug 15;222(1):57-64. doi: 10.1042/bj2220057.
4
Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.磺胺吡啶、5-氨基水杨酸和安慰剂对特发性直肠炎患者的影响:一项确定柳氮磺胺吡啶活性治疗成分的研究。
Gut. 1980 Jul;21(7):632-5. doi: 10.1136/gut.21.7.632.
5
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.柳氮磺胺吡啶用于溃疡性结肠炎维持治疗的最佳剂量。
Gut. 1980 Mar;21(3):232-40. doi: 10.1136/gut.21.3.232.
6
Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.柳氮磺胺吡啶治疗期间的不良反应及其与药物代谢和乙酰化酶表型的关系。
N Engl J Med. 1973 Sep 6;289(10):491-5. doi: 10.1056/NEJM197309062891001.
7
Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy.偶氮双水杨酸二钠和柳氮磺胺吡啶对永久性回肠造口术患者回肠造口液输出量及前列腺素E2和前列腺素F2α的影响。
Gut. 1986 Nov;27(11):1306-11. doi: 10.1136/gut.27.11.1306.
8
An experiment to determine the active therapeutic moiety of sulphasalazine.一项确定柳氮磺胺吡啶活性治疗部分的实验。
Lancet. 1977 Oct 29;2(8044):892-5. doi: 10.1016/s0140-6736(77)90831-5.